Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Kei Sakamoto
Japan Patient Safety, AstraZeneca K.K., Japan
Poster(s):
(051) Incidence of Diabetic Ketoacidosis in Dapagliflozin Users vs. SGLT2i Non-users with Type 1 Diabetes Mellitus using a Japanese Claims Database
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST